Globaldata plc LSE:DATA
- Incorporated
- United Kingdom
- Chief executive
- Mike Danson
- Employees
- 3,655
- Reports in
- GBP
- Companies House
- 03925319
Read straight from the annual reports
59.0p at close on 8 Oct 2026 · 11 reported years, 2015–2025
| Line | FY201512/15 | FY201612/16 | FY201712/17 | FY201812/18 | FY201912/19 | FY202012/20 | FY202112/21 | FY202212/22 | FY202312/23 | FY202412/24 | FY202512/25 | FY2026unreported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Gross profit | — | — | — | — | ||||||||
| Operating profit | ||||||||||||
| Exceptional items | — | |||||||||||
| Net finance cost | ||||||||||||
| Profit before tax | ||||||||||||
| Adjusted profit before tax | — | — | — | — | — | — | — | |||||
| Tax charge | ||||||||||||
| Profit for the year | ||||||||||||
| EBITDA | ||||||||||||
| Adjusted minus statutory PBT | — | — | — | — | — | — | — | |||||
| Basic EPS | ||||||||||||
| Diluted EPS | ||||||||||||
| Adjusted EPS | — | — | — | — | — | — | — | |||||
| Dividend per share |
GBP millions, negatives in brackets. Per-share lines in pence, share counts in millions. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated. The share price above is drawn to the same columns: each close sits over the financial year it fell in.
11 years, at a glance
Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.
GlobalData Plc sells data, analysis and research to businesses, mostly by subscription. In 2025 its revenue rose 12.8% to £322.1m, and profit after tax rose to £33.1m from £29.6m. Most of the growth came from buying other companies, which added £39m of revenue; the existing business grew very little. Spending on a sales overhaul and on absorbing recent purchases cut its margin before one-off items, and the report notes weaker demand from drug companies. Reported profit was helped by a non-cash accounting gain, because staff share awards were judged unlikely to pay out, partly offset by restructuring and acquisition costs. The company ended the year with £51.1m of cash, but borrowings rose to £165.3m while it spent £112.5m buying back its own shares. The dividend for the year was cut to 1.5p. Management says the company is well placed for 2026 and expects margins to recover as integration work ends. The auditor gave a clean opinion, and the directors raised no doubt about the company's future.
Subscription revenue (recurring), ~74% of total revenue in 2025
"subscriptions making up 74% of revenue" (2024: 75%)
page 26Acquisitions contributing £39.0m of incremental 2025 revenue
Revenue bridge: Revenue 2024 £285m + Impact of FX (£4m) + Acquisitions £39m + Organic growth £2m = Revenue 2025 £322m
page 21Investment in sales transformation, strategic account management and corporate infrastructure
Adjusted EBITDA margin fell to 34% (2024: 41%) reflecting Growth Transformation Plan investment
page 17Dilutive impact of six recent acquisitions during integration phase
M&A completed Aug 2024–Jul 2025 were margin dilutive due to timing and unrealised cost synergies
page 18"We have entered 2026 well positioned to drive long-term sustainable growth, as well as return to Adjusted EBITDA margin of 40%" – Murray Legg, Chair
page 10Admission to the Main Market of the London Stock Exchange expected 8:00am on 5 March 2026 (move from AIM)
page 11Progressive dividend policy, rebased from 1 July 2024 to prioritise free cash flow toward value-creating M&A. Proposed final dividend of 1.2p (2024: 1.0p), total dividend for 2025 of 1.5p (2024: 2.5p, -40% reflecting the rebasing), payable 1 May 2026
page 11Directors prepared accounts on a going concern basis. Net bank debt £114.2m at 31 Dec 2025 (2024: net cash £10.1m); undrawn RCF of £217.0m; base case and reverse stress-test scenarios modelled to September 2027 with no indication of covenant breach. Auditor Deloitte LLP (6th year, audit engagement partner Scott Bayne) issued an unqualified opinion with Key Audit Matters on consulting revenue recognition accuracy and impairment of goodwill relating to Washington Topco
page 128Read from C000549-AR-2025-nsm.
10 annual reports read, FY2016 to FY2025
Open a year to see what its report said. Every line in it carries the page it was read from.
Sources: Companies House (9), FCA NSM (1)
FY2026Next report expected 8 Mar 2027